<- Go Home
STAAR Surgical Company
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) and laser-based procedures, such as LASIK to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
Market Cap
$1.3B
Volume
1.0M
Cash and Equivalents
$176.2M
EBITDA
-$54.0M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$170.3M
Profit Margin
73.87%
52 Week High
$30.81
52 Week Low
$13.50
Dividend
N/A
Price / Book Value
3.68
Price / Earnings
-13.52
Price / Tangible Book Value
3.99
Enterprise Value
$1.2B
Enterprise Value / EBITDA
-25.09
Operating Income
-$62.7M
Return on Equity
24.65%
Return on Assets
-7.88
Cash and Short Term Investments
$192.7M
Debt
$39.1M
Equity
$353.8M
Revenue
$230.6M
Unlevered FCF
$13.5M
Sector
Health Care Equipment and Supplies
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium